Small-for-size liver graft injury-impact on tumor behavior

Transplantation Reviews

Volumn 24, Issue 1, 2010, Pages 1-10

  Shih, Kendrick Co ^a   Man, Kwan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; EARLY GROWTH RESPONSE FACTOR 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; FOCAL ADHESION KINASE; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CELL ADHESION; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; INFLAMMATION; LIVER CELL CARCINOMA; LIVER ISCHEMIA; LIVER RESECTION; LIVER SIZE; LIVER TRANSPLANTATION; LIVER WEIGHT; LIVING DONOR; METASTASIS POTENTIAL; MICROVASCULAR ISCHEMIA; NONHUMAN; PATIENT SAFETY; PORTAL HYPERTENSION; PROTEIN EXPRESSION; RECURRENCE RISK; THERAPY EFFECT; TREATMENT OUTCOME; TUMOR RECURRENCE;

EID: 70449701469     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2009.06.004     Document Type: Article

References (81)

1. Berg C.L., Gillespie B.W., Merion R.M., et al. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 133 (2007) 1806-1813
2. Russo M.W., LaPointe-Rudow D., Kinkhabwala M., et al. Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation. Am J Transplant 4 (2004) 427-431
3. Kim W.R., Therneau T.M., Bension J.T., et al. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 43 (2006) 345-351
4. Sarasin F.P., Majno P.E., Llovet J.M., et al. Living donor liver transplantation for early hepatocellular carcinoma: a life expectancy and cost-effectiveness perspective. Hepatology 33 (2001) 1073-1079
5. Cheng S.J., Pratt D.S., Freeman Jr. R.B., et al. Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 72 (2001) 861-868
6. Lo C.M., Fan S.T., Liu C.L., et al. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 10 (2004) 440-447
7. Man K., Fan S.T., Lo C.M., et al. Graft injury in relation to graft size in right lobe live donor liver transplantation. Ann Surg 237 (2003) 256-264
8. Abt P.L., Mange K.C., Olthoff K.M., et al. Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 4 (2004) 1302-1307
9. Thuluvath P.J., and Yoo H.Y. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl 10 (2004) 1263-1268
10. Fisher R.A., Kulik L.M., Freise C.E., et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 7 (2007) 1601-1608
11. Lo C.M., Fan S.T., Liu C.L., et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 94 (2007) 78-86
12. Kulik L., and Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 127 (2004) S277-S282
13. Tanaka K., and Ogura Y. "Small-for-size graft" and "small-for-size syndrome" in living donor liver transplantation. Yonsei Med J 45 (2004) 1089-1094
14. Surman O., and Hertl M. Liver donation: donor safety comes first. Lancet 362 (2003) 674-675
15. Starzl T., Koep L.J., Weil R., et al. Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstetr 150 (1980) 208-214
16. Schindl M.J., Redhead D.N., Fearon K.C., et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54 (2005) 289-296
17. Lo C.M., Fan S.T., Liu C.L., et al. Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg 226 (1997) 261-269
18. Chan S.C., Liu C.L., Lo C.M., et al. Donor quality of life before and after adult-to-adult right liver live donor liver transplantation. Liver Transpl 12 (2006) 1529-1536
19. Umeshita K., Fujiwara K., Kiyosawa K., et al. Operative morbidity of living donors in Japan. Lancet 362 (2003) 687-690
20. Boillot O., Dawahra M., and Méchet I. Liver transplantation using a right liver lobe from a living donor. Transplant Proc 34 (2002) 773-776
21. Chan S.C., Fan S.T., Lo C.M., et al. Towards current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases. Ann Surg 245 (2007) 110-117
22. Furukawa H., Kishida A., Omura T., et al. Indication and strategy for adult living related liver transplantation. Transplant Proc 31 (1999) 1952
23. Emond J.C., Renz J.F., Ferrell L.D., et al. Functional analysis of grafts from living donors: implications for treatment of older recipients. Ann Surg 244 (1996) 544-552
24. Kiuchi T., Kasahara M., Uryuhara K., et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 67 (1999) 321-327
25. Urata K., Kawasaki S., Matsunami H., et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 21 (1995) 1317-1321
26. Kiuchi T., Tanaka K., Ito T., et al. Small-for-size graft in living donor liver transplantation: how far should we go?. Liver Transpl 9 (2003) S29-S35
27. Fan S.T. Live donor liver transplantation in adults. Transplantation 82 (2006) 723-732
28. Man K., Lo C.M., Ng I.O., et al. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg 136 (2001) 280-285
29. Ayuse T., Brienza N., O'Donnell C.P., et al. Pressure-flow analysis of portal vein and hepatic artery interactions in porcine liver. Am J Physiol 267 (1994) H1233-H1242
30. Haddad F. Hepatic blood flow (1999), Oxford Textbook of Clinical Hepatology 77
31. Bolognesi M Sacerdoti D., Bombonato G., et al. Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size. Hepatology 35 (2002) 601-608
32. Henderson J.M., Gilmore G.T., Mackay G.J., et al. Hemodynamics during liver transplantation: the interactions between cardiac output and portal venous and hepatic arterial flows. Hepatology 16 (1992) 715-718
33. Kelly D.M., Demetris A.J., Fung J.J., et al. Porcine partial liver transplantation: a novel model of the small-for-size liver graft. Liver Transpl 10 (2004) 253-256
34. Vollmar B., Glasz J., Leiderer R., et al. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145 (1994) 1421-1431
35. Rodriguez A.A., LaMorete W.W., Hanrahan L.M., et al. Liver viability after ischemia-reperfusion. Arch Surg 126 (1991) 767-772
36. Panis Y., McMullan D.M., and Emond J.C. Progressive necrosis after hepatectomy and the pathology of liver failure after massive resection. Surgery 121 (1997) 142-149
37. Fujiwara K., Mochida S., Ohno A., et al. Possible cause of primary graft non-function after orthotopic liver transplantation: a hypothesis with rat models. J Gastroenterol Hepatol 10 (1995) S88-S91
38. Garcia-Pagan J.C., Zhang J.X., Sonin N., et al. Ischemia/reperfusion induces an increase in the hepatic portal vasoconstrictive response to endothelin-1. Shock 11 (1999) 325-329
39. Yamagisawa M Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
40. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31 (1999) 577-596
41. Mashimo H., and Goyal R.K. Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. Am J Physiol 277 (1999) G745-G750
42. Matsumoto K., Honda K., and Kobayashi N. Protective effect of heat preconditioning of rat liver graft resulting in improved transplant survival. Transplantation 71 (2001) 862-868
43. Duckers H.J., Boehm M., True A.L., et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7 (2001) 693-698
44. Zhong Z., Connor H.D., Froh M., et al. Free radical-dependent dysfunction of small-for-size rat liver grafts: prevention by plant polyphenols. Gastroenterology 129 (2005) 652-654
45. Santori G., Andorno E., Fontana I., et al. Effects of ischemia-reperfusion on hepatic glutathione and plasmatic markers of graft function during in situ split-liver transplantation in adult recipients. Dig Dis Sci 45 (2000) 1981-1987
46. Liu P., McGuire G.M., Fisher M.A., et al. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock 3 (1995) 56-62
47. Yang Z.F., Ho D.W., Chu A.C., et al. Linking Inflammation in small-for-size allografts: the potential role of early macrophage activation. Am J Transplant 4 (2004) 196
48. Yang Z.F., Poon R.T., and Luo Y. Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor-2 dependent pathway. J Immunol 173 (2004) 2507-2515
49. Dahm F., Georgiev P., and Clavien P.A. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 5 (2005) 2605-2610
50. Kawasaki S., Makuuchi M., Matsunami H., et al. Living related liver transplantation in adults. Ann Surg 227 (1998) 269-274
51. Nishizaki T., Ikegami T., Hiroshige S., et al. Small graft for living donor liver transplantation. Ann Surg 233 (2001) 575-580
52. Lo C.M., Fan S.T., Liu C.L., et al. Minimum graft size for successful living donor liver transplantation. Transplantation 68 (1999) 1112-1116
53. Ben-Haim M., Emre S., Fishbein T.M., et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of recipient's disease. Liver Transpl 7 (2001) 948-953
54. Zhong Z., Schwabe R.F., Kai Y., et al. Liver regeneration is suppressed in small-for-size liver grafts after transplantation: involvement of c-jun N-terminal kinase, cyclin D1, and defective energy supply. Transplantation 82 (2006) 241-250
55. Hickman R., Stapleton G.N., Mets B., et al. Hepatic blood flow during reduced liver grafting in pigs: a comparison of controls and recipients of intact allografts. Dig Dis Sci 40 (1995) 1246-1251
56. Yamamoto H., Maetani Y., Kiuchi T., et al. Background and clinical impact of tissue congestion in right-lobe living-donor liver grafts: a magnetic resonance imaging study. Transplantation 76 (2003) 164-169
57. Lo C.M. Nonalcoholic steatohepatitis in donors for living donor liver transplantation. Transplantation 83 (2007) 265-266
58. Soejima Y., Shimada M., Suehiro T., et al. Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl 9 (2003) 581-586
59. Maluf D.G., Stravitz R.T., Cotterell A.H., et al. Adult living donor versus deceased donor liver transplantation: a 6-year single center experience. Am J Transplant 5 (2005) 149-156
60. Bismuth H., Chiche L., Adam R., et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218 (1993) 145-155
61. Mazzaferro V., Battiston C., Perrone S., et al. Liver transplantation for treatment of small hepatocellular carcinomas in patient with cirrhosis. N Engl J Med 334 (1996) 693-699
62. Llovet J.M., Fuster J., Bruix J., et al. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30 (1999) 1434-1440
63. Hwang S., Lee S.G., Joh J.W., et al. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 11 (2005) 1265-1272
64. Gondolesi G.E., Roayaie S., Muñoz L., et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS Priority Criteria. Ann Surg 239 (2004) 142-149
65. Hwang S., Lee S.G., Ahn C.S., et al. Small-sized liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation. Transplant Proc 39 (2007) 1526-1529
66. Doi K., Horiuchi T., Uchinami M., et al. Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. J Surg Res 105 (2002) 243-247
67. van der Bilt J.D., Kranenburg O., Nijkamp M.W., et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardised murine model. Hepatology 42 (2005) 165-175
68. Man K., Ng K.T., Lo C.M., et al. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases-activation of cell invasion and migration pathways. Liver Transpl 13 (2007) 1669-1677
69. Man K., Lo C.M., Xiao J.W., et al. The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg 247 (2008) 1049-1057
70. Fahmy R.G., Dass C.R., Sun L.Q., et al. Transcription of factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 9 (2003) 1026-1032
71. von Sengbusch A., Gassmann P., Fisch K.M., et al. Focal adhesion kinase regulates metastatic adhesion of carcinoma cells with liver sinusoids. Am J Pathol 166 (2005) 585-596
72. Lee S.H., Wolf P.L., Escudero R., et al. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342 (2000) 626-633
73. Yoshida M., Horiuchi T., Uchinami M., et al. Intermittent hepatic ischemia-reperfusion minimizes liver metastasis in rats. J Surg Res 111 (2003) 255-260
74. Leeuwenberg J.F., Jeunhomme T.M., Buurman W.A., et al. Role of ELAM-1 in adhesion of monocytes to activated human endothelial cells. Scand J Immunol 35 (1992) 335-341
75. Bevilacqua M.P., Stengelin S., Gimbrone M.A., et al. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243 (1989) 1160-1165
76. Uotani H., Yamashita I., Nagata T., et al. Induction of E-selectin after partial hepatectomy promotes metastases to liver in mice. J Surg Res 96 (2001) 197-203
77. Nemoto Y., Izumi Y., Tezuka K., et al. Comparison of 16 human colon carcinoma cell lines for their expression of sialyl LeX antigens and their E-selectin-dependent adhesion. Clin Exp Metastasis 16 (1998) 569-576
78. Wyble C.W., Hynes K.L., Kuchibhotia J., et al. TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway. J Surg Res 73 (1997) 107-112
79. Suzuki S., and Toledo-Pereyra L.H. Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 57 2 (1994) 253-258
80. Corral C.J., Siddiqui A., Wu L., et al. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg 134 (1999) 200-205
81. van der Bilt J.D., and Borel Rinkes I.H. Surgery and angiogenesis. Biochem Biophys Acta 1654 (2004) 95-104